Blood Leukocyte AHRR Methylation and Risk of Non-smoking-associated Cancer: A Case-cohort Study of Non-Hodgkin Lymphoma.
Christina DahlUlla Arthur HvidtfeldtAnne TjønnelandPer GuldbergOle Raaschou-NielsenPublished in: Cancer research communications (2023)
methylation as a biomarker for NHL risk, effective up to 10 years after blood draw.